It was observed that betulinaldehyde suppresses the activation of Akt, MAPK, and STAT3 signaling pathways in A549 cells in a time-dependent manner and modulates intracellular autophagy levels, significantly inhibiting tumor activity in A549 cells, suggesting its potential as an effective adjuvant therapy for lung cancer (24). The gene discussed is AKT1; the disease is neoplasm.